<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/960F2E0B-E517-4D36-A13D-12780591CD6A"><gtr:id>960F2E0B-E517-4D36-A13D-12780591CD6A</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:otherNames>Mark</gtr:otherNames><gtr:surname>Fishman</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100397"><gtr:id>2B405A4A-C789-46C6-8F0A-5A8336EDA993</gtr:id><gtr:title>Molecular and functional characterisation of tissue-engineered skeletal muscle constructs.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1100397</gtr:grantReference><gtr:abstractText>Diseases that affect skeletal muscle are devastating. Such conditions include children who are born with diseases such as Duchenne muscular dystrophy and those born with a blind-ending food-pipe who are unable to feed properly. Adults may also succumb to the effects of skeletal muscle loss (following conditions such as trauma, or cancer that may, for example, result in amputation or require an operation to remove a cancerous food-pipe) with equally devastating functional effects.

Tissue-engineering aims to grow tissues in the laboratory by seeding stem cells on to a scaffold. These tissues can then be used to replace diseased ones. Often, the patient?s own stem cells are used, so the tissue is not rejected by the immune system.

Our aim is to tissue-engineer skeletal muscle by growing immature muscle cells in the laboratory and seeding them on to a scaffold. We have had encouraging results with tissue-engineering human wind-pipes in adults and a child. Our research will aim to tissue-engineer a food-pipe that contains skeletal muscle in its upper portion.

Important extensions of the project include the development of methods which might help treat diseases of other hollow organs that possess muscle, including diseases of the bowel, bladder and larynx.</gtr:abstractText><gtr:technicalSummary>Aims
The over-riding goal of this proposal is to develop an in vitro tissue-engineered skeletal muscle replacement.

Objectives
1. Expansion and characterisation of skeletal muscle precursor cells in tissue culture.
2. Functional assessment of cells.
3. Preparation and characterisation of a decellularised scaffold.
4. Seeding of cells to the scaffold.
5. Functional status of the tissue-engineered constructs in vitro.
6. In vivo studies.

Design and Methodology

Expansion and characterisation of skeletal muscle precursor cells in tissue culture
Rodent skeletal muscle precursor cells will be isolated, expanded in cell culture and characterised using immunofluoresence and semi-quantitative RT-PCR for known myocyte markers. Cells will be compared to differentiated adult myocytes and C2C12 myoblasts. Use of GFP mice will enable cells to be tracked.

Functional assessment of cells
Contractile status of the cells will be measured with a collagen lattice contraction assay and time-lapse microscopy.

Preparation and characterisation of a decellularised scaffold
Rat oesophagus will be decellularised using detergent-enzymatic treatments (sodium deoxycholate and DNase) and the scaffold characterised. The decellularised scaffold will be assessed with histology, immunohistology (for muscle, connective tissue and HLA-components), DNA and collagen assays, western blotting. 

Tensile stress studies will be conducted and its mechanical properties will be compared with control oesophagus (stress/strain relationship). The optimal number of cycles of detergent-enzymatic treatments will be determined (trade-off between loss of immunogenicity with increasing cycles vs. loss of mechanical and structural properties).

Seeding of cells to the scaffold
Cells will be seeded to the decellularised scaffold with a rotating bioreactor. Seeded constructs will be rigorously assessed with histology, immunohistology, scanning electron microscopy.

Functional status of the tissue-engineered constructs in vitro
Physiological organ bath studies evaluating the contraction of muscle tissue upon pharmacological or electrical stimulation. Tissue-engineered constructs will be compared with control rat oesophagus.

In vivo studies
A further research proposal is envisaged to continue the experimentation in vivo, implanting constructs into rodents.

Scientific and medical opportunities
Tissue-engineered solutions have the major advantage of not requiring immunosuppression, but are presently limited to static organs and tissues, such as skin and trachea, or those which can function through passive movement alone, such as heart valves, blood vessels and bladder. The ability to produce functioning muscles would hugely extend the possible applications of regenerative medicine.</gtr:technicalSummary><gtr:fund><gtr:end>2014-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>146013</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Surgical Sciences Oxford</gtr:department><gtr:description>Transplantation immunology</gtr:description><gtr:id>BDAACB32-D44C-4276-B81A-1CDF870BAB06</gtr:id><gtr:impact>PMID: 23940349</gtr:impact><gtr:outcomeId>Mp9qVL9jHBP-1</gtr:outcomeId><gtr:partnerContribution>Assistance with experimental design.</gtr:partnerContribution><gtr:piContribution>Collaboration with Prof. Kathryn Wood's Team in Oxford (PMID: 23940349).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Royal College of Surgeons of England Research Evening to Charities and Lay-people</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>64E7B489-FB6C-43D5-94C4-357B458A2974</gtr:id><gtr:impact>Talk to around 100 charity persons and lay-people

.</gtr:impact><gtr:outcomeId>Eu7BnpQ2SBZ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sparks and MRC Children's Charity Engagement</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F6CA9198-D431-4240-AE41-56AC6E62C30C</gtr:id><gtr:impact>.</gtr:impact><gtr:outcomeId>ce9J6hcXd8T</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to Freemasons</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7098268C-B0F9-458C-8C2B-770E091EF109</gtr:id><gtr:impact>Talk to around 500 Freemasons

.</gtr:impact><gtr:outcomeId>hGEzFtAkmcQ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences Clinical Lecturer Starter Grant</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:fundingRef>AMS-SGCL13-Fishman (A tissue-engineered approach to laryngeal regeneration)</gtr:fundingRef><gtr:id>AE6F1E7F-0D7F-4B1B-AAD3-896C6412A27B</gtr:id><gtr:outcomeId>56d47df9862135.76116476</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>44612</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Award</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>1TAG</gtr:fundingRef><gtr:id>C7325B54-042A-4260-9C81-3F8C9A90B402</gtr:id><gtr:outcomeId>K8o9kZ933TX</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>55087FC1-02E2-4B03-8A4B-3299F4E3B7B5</gtr:id><gtr:title>What can regenerative medicine offer for infants with laryngotracheal agenesis?</gtr:title><gtr:parentPublicationTitle>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7e875c741084b1cc15afd65eec384ea"><gtr:id>c7e875c741084b1cc15afd65eec384ea</gtr:id><gtr:otherNames>Lange P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0194-5998</gtr:issn><gtr:outcomeId>pm_13586_26_21860060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>039DA553-0DC5-4159-A532-0082220E68A3</gtr:id><gtr:title>The current status of human laryngeal transplantation in 2017: A state of the field review.</gtr:title><gtr:parentPublicationTitle>The Laryngoscope</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42e1292108974fba735bfed208e83262"><gtr:id>42e1292108974fba735bfed208e83262</gtr:id><gtr:otherNames>Krishnan G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0023-852X</gtr:issn><gtr:outcomeId>58b6e27fa5f037.96032440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>912C2950-467A-49B5-A631-520CBEFEE3F6</gtr:id><gtr:title>Regenerative medicine in otorhinolaryngology.</gtr:title><gtr:parentPublicationTitle>The Journal of laryngology and otology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe12328e1e2b147ae775d0ffe9e1aa78"><gtr:id>fe12328e1e2b147ae775d0ffe9e1aa78</gtr:id><gtr:otherNames>Wormald JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2151</gtr:issn><gtr:outcomeId>56d477fa2266b2.91153798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>315E7DFC-E922-46F9-B29F-13CDA35111F3</gtr:id><gtr:title>Esophageal tissue engineering: a new approach for esophageal replacement.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36fb2e6a077c8486c02b63417c4943ad"><gtr:id>36fb2e6a077c8486c02b63417c4943ad</gtr:id><gtr:otherNames>Totonelli G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn><gtr:outcomeId>pm_13586_26_23322987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4214B42A-CFA5-44D3-81E6-38CFD1710D20</gtr:id><gtr:title>Stem cell approaches for vocal fold regeneration.</gtr:title><gtr:parentPublicationTitle>The Laryngoscope</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0023-852X</gtr:issn><gtr:outcomeId>56d478ba3fd0b6.08204536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1C6C079-F34B-4F8E-8985-958964E9EF9E</gtr:id><gtr:title>Characterisation and immunogenicity of a decellularised skeletal muscle scaffold for laryngeal tissue engineering</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f76b97de4dfd07d31050217a9914e398"><gtr:id>f76b97de4dfd07d31050217a9914e398</gtr:id><gtr:otherNames>Fishman J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>NoiKgLTWpcC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8B74F9D-9A9C-443E-815C-1C0B14F60F7B</gtr:id><gtr:title>Airway tissue engineering: an update.</gtr:title><gtr:parentPublicationTitle>Expert opinion on biological therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2598</gtr:issn><gtr:outcomeId>545a6ccc3baa61.17502338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ABEFB04-88FF-45AA-B0F1-8DA8E03D843E</gtr:id><gtr:title>Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13586_26_23940349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13DCBB4C-E309-4F79-94CE-FF2BB367416B</gtr:id><gtr:title>Airway tissue engineering.</gtr:title><gtr:parentPublicationTitle>Expert opinion on biological therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2598</gtr:issn><gtr:outcomeId>pm_13586_26_21973083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>447D89ED-D032-4E9C-AF95-7E76ED3CC756</gtr:id><gtr:title>Alternative injectable materials for vocal fold medialisation in unilateral vocal fold paralysis.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d173e2bff3e019f301e52bfea0395bb3"><gtr:id>d173e2bff3e019f301e52bfea0395bb3</gtr:id><gtr:otherNames>Lakhani R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>pm_13586_26_23076955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEA96248-305F-454B-8AD1-59D5260D96B3</gtr:id><gtr:title>A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36fb2e6a077c8486c02b63417c4943ad"><gtr:id>36fb2e6a077c8486c02b63417c4943ad</gtr:id><gtr:otherNames>Totonelli G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>pm_13586_26_22305104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93E715F5-14A0-45E8-9632-C607A0A24D63</gtr:id><gtr:title>Decellularized rabbit cricoarytenoid dorsalis muscle for laryngeal regeneration.</gtr:title><gtr:parentPublicationTitle>The Annals of otology, rhinology, and laryngology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-4894</gtr:issn><gtr:outcomeId>pm_13586_26_22397223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A77B482-8E0E-45C1-A7E4-E0562BA29A07</gtr:id><gtr:title>Skeletal muscle tissue engineering: which cell to use?</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part B, Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1937-3368</gtr:issn><gtr:outcomeId>pm_13586_26_23679017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E89E9BF9-D8E0-4315-806D-6D46CB4DF5E4</gtr:id><gtr:title>Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissues.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>5675dd204199a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>823BF32E-AFD7-4D7F-AB6E-2359288F532A</gtr:id><gtr:title>Stem cell-based organ replacements-airway and lung tissue engineering.</gtr:title><gtr:parentPublicationTitle>Seminars in pediatric surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1055-8586</gtr:issn><gtr:outcomeId>545a6ccc64ba72.12208154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A19B4BE-97CA-4F1E-8D29-460A3F663815</gtr:id><gtr:title>The Host Immune Response to Tissue-Engineered Organs: Current Problems and Future Directions.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part B, Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acbf829c2329a51f3f263517c917ee6f"><gtr:id>acbf829c2329a51f3f263517c917ee6f</gtr:id><gtr:otherNames>Wiles K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1937-3368</gtr:issn><gtr:outcomeId>56d47842c68b53.37814019</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100397</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>